2011
DOI: 10.1016/j.ejmech.2011.05.012
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of new chalcone derivatives bearing 2,4-thiazolidinedione and benzoic acid moieties as potential anti-bacterial agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
29
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 104 publications
(29 citation statements)
references
References 7 publications
0
29
0
Order By: Relevance
“…Liu et al 16 Synthesized a series of chalcone derivatives bearing the 2,4-thiazolidinedione and benzoic acid moieties evaluated for their antibacterial activity. In tested compounds, the most effective results obtained with MIC value in the range of 0.5-4mg/mL against six Gram-positive bacteria.…”
Section: As Anti-inflammatory Agentmentioning
confidence: 99%
“…Liu et al 16 Synthesized a series of chalcone derivatives bearing the 2,4-thiazolidinedione and benzoic acid moieties evaluated for their antibacterial activity. In tested compounds, the most effective results obtained with MIC value in the range of 0.5-4mg/mL against six Gram-positive bacteria.…”
Section: As Anti-inflammatory Agentmentioning
confidence: 99%
“…From the big family of heterocyclic compounds, 1,3-thiazolidine-2,4-diones show a wide spectrum of chemo -therapeutic properties and a considerable amount of work has been done on the synthesis of thiazolidinedione derivatives as potent antibacterial and antifungal agents (Gouveia et al, 2009, Liu et al, 2011. Chromone and related compounds are wide-spread in nature and exhibit a wide range of pharmacological activity like antibacterial, antifungal (Hatzade et al, 2010, Ali andIbrahim, 2010), antitumor, anti-oxidant, anti-HIV, antiulcerant, anti-inflammatory.…”
Section: Sirmentioning
confidence: 99%
“…Correspondingly, chalcones bearing 2,4-thiazolidinedione and benzoic acid moieties (VIII) presented potential anti-bacterial activity against gram positive bacteria, particularly against multidrug-resistant strains of clinical isolates [28]. Moreover, integration of 5-nitroisoquinolines (IX) and Abacavir prodrugs (X) with Schiff bases enhanced the anti-malarial and anti-HIV scope of these compounds [29,30].…”
Section: Introductionmentioning
confidence: 99%